Structure-based discovery of A2A adenosine receptor ligands.
The recent determination of X-ray structures of pharmacologically relevant GPCRs has made these targets accessible to structure-based ligand discovery. Here we explore whether novel chemotypes may be discovered for the A(2A) adenosine receptor, based on complementarity to its recently determined structure. The A(2A) adenosine receptor signals in the periphery and the CNS, with agonists explored as anti-inflammatory drugs and antagonists explored for neurodegenerative diseases. We used molecular docking to screen a 1.4 million compound database against the X-ray structure computationally and tested 20 high-ranking, previously unknown molecules experimentally. Of these 35% showed substantial activity with affinities between 200 nM and 9 microM. For the most potent of these new inhibitors, over 50-fold specificity was observed for the A(2A) versus the related A(1) and A(3) subtypes. These high hit rates and affinities at least partly reflect the bias of commercial libraries toward GPCR-like chemotypes, an issue that we attempt to investigate quantitatively. Despite this bias, many of the most potent new ligands were novel, dissimilar from known ligands, providing new lead structures for modulation of this medically important target.
Carlsson
Jens
J
Department of Pharmaceutical Chemistry, University of California, 1700 4th Street, Box 2550, San Francisco, California 94158, USA.
Yoo
Lena
L
Gao
Zhan-Guo
ZG
Irwin
John J
JJ
Shoichet
Brian K
BK
Jacobson
Kenneth A
KA
D000893:Anti-Inflammatory Agents / Q000737:chemistry*; D003198:Computer Simulation; D055808:Drug Discovery; D006801:Humans; D008024:Ligands; D019636:Neurodegenerative Diseases / Q000188:drug therapy*; D011485:Protein Binding; D043705:Receptor, Adenosine A2A / Q000187:drug effects* / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled; D054852:Small Molecule Libraries; D013329:Structure-Activity Relationship
D000893:Anti-Inflammatory Agents; D008024:Ligands; D043705:Receptor, Adenosine A2A; D043562:Receptors, G-Protein-Coupled; D054852:Small Molecule Libraries
J Med Chem. 2003 Sep 25;46(20):4265-72
13678405
Handb Exp Pharmacol. 2009;(193):215-69
19639284
Anal Biochem. 1990 Sep;189(2):231-4
2177960
Anal Biochem. 1976 May 7;72:248-54
942051
Science. 2008 Nov 21;322(5905):1211-7
18832607
J Chem Inf Model. 2006 Jan-Feb;46(1):365-79
16426071
Curr Top Med Chem. 2005;5(8):739-49
16101414
Science. 2007 Nov 23;318(5854):1258-65
17962520
Neuropharmacology. 1997 Sep;36(9):1157-65
9364471
Nat Rev Drug Discov. 2006 Mar;5(3):247-64
16518376
Nature. 2008 Jul 24;454(7203):486-91
18594507
Br J Pharmacol. 2010 Mar;159(5):986-96
19912230
Proteins. 1999 Jan 1;34(1):4-16
10336382
Br J Pharmacol. 1995 Jul;115(6):1096-102
7582508
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6843-8
19342484
J Biol Chem. 1995 Jun 9;270(23):13987-97
7775460
J Am Chem Soc. 2005 Apr 6;127(13):4632-9
15796528
J Med Chem. 2008 Aug 28;51(16):4978-85
18680279
Handb Exp Pharmacol. 2009;(193):59-98
19639279
J Mol Graph Model. 2003 Mar;21(5):449-62
12543140
Nat Biotechnol. 2007 Feb;25(2):197-206
17287757
J Mol Biol. 1997 Apr 4;267(3):727-48
9126849
Structure. 2002 Jul;10(7):1013-23
12121656
J Biol Chem. 2003 Jul 11;278(28):25990-7
12676933
Mol Pharmacol. 1994 May;45(5):978-82
8190112
Protein Eng. 1993 Sep;6(7):723-32
7504257
Bioorg Med Chem. 2003 Jan 2;11(1):77-85
12467710
Bioorg Med Chem Lett. 2008 Oct 15;18(20):5391-5
18829308
J Chem Inf Model. 2005 Jan-Feb;45(1):177-82
15667143
Science. 2007 Nov 23;318(5854):1266-73
17962519
Med Res Rev. 2006 Mar;26(2):131-59
16380972
J Med Chem. 2008 Apr 24;51(8):2502-11
18333608
J Mol Recognit. 2009 Jul-Aug;22(4):307-18
19353579
J Mol Biol. 2002 Sep 13;322(2):339-55
12217695
J Comput Chem. 1986 Apr;7(2):230-252
29160584
Biochem Pharmacol. 2002 Jul 1;64(1):61-5
12106606
Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6):679-83
2615857
ChemMedChem. 2006 Aug;1(8):854-68
16902939
Nat Rev Drug Discov. 2006 Dec;5(12):993-6
17139284
J Med Chem. 2010 Feb 25;53(4):1799-809
20095623
J Comput Aided Mol Des. 2009 May;23(5):273-88
19148767
J Pharmacol Exp Ther. 1989 Dec;251(3):888-93
2600819
Methods Mol Biol. 2000;126:363-74
10685423
Handb Exp Pharmacol. 2009;(193):471-534
19639292
Protein Sci. 1998 Apr;7(4):938-50
9568900
J Mol Biol. 1982 Oct 25;161(2):269-88
7154081
Protein Sci. 2005 Apr;14(4):1104-14
15772311
Nat Chem Biol. 2009 Jul;5(7):479-83
19483698